Sakunrat Prompalit

Sakunrat Prompalit

Auto-generated profile, based on publicly available information

Sakunrat Prompalit

Department of Biomedical Engineering, University of California Davis, Davis, California, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in BioMed Research International
Verified
Journal Article
Open access
PDF file
UTUdomchai Techavipoo
Udomchai Techavipoo
NSNattawut Sinsuebphon
Nattawut Sinsuebphon
SPSakunrat Prompalit
Sakunrat Prompalit
STSaowapak Thongvigitmanee
Saowapak Thongvigitmanee
WNWalita Narkbuakaew
Walita Narkbuakaew
UCUtairat Chaumrattanakul
Utairat Chaumrattanakul
Background. The National Science and Technology Development Agency (NSTDA) in Thailand researched and prototyped digital radiography systems under the brand name BodiiRay aiming for sustainable development and affordability of medical imaging technology. The image restoration and enhancement were implemented for the systems. Purpose. The image quality of the systems was evaluated using images from phantoms and from healthy volunteers. Methods. The survey phantom images from BodiiRay and other two commercial systems using the exposure settings for the chest, the abdomen, and the extremity were evaluated by three experience observers in terms of the high‐contrast image resolution, the low‐contrast image detectability, and the grayscale differentiation. The volunteer images of the chests, the abdomens, and the extremities from BodiiRay were evaluated by three specialized radiologists based on visual grading on 5‐point scaled questionnaires for the anatomy visibility, the image quality satisfaction, and the diagnosis confidence in using the images. Results. BodiiRay phantom results were similar to those from the commercial systems. The overall performance averaged across the exposure settings showed that BodiiRay was slightly better than Fujifilm FDR Go in the low‐contrast detectability (p = 0.033) and in the grayscale differentiation (p = 0.004). It was also slightly better than Siemens YSIO Max in the high‐contrast resolution (p = 0.018). The images of chest, pelvis, and hand phantoms illustrated comparable visual quality. For volunteer images, the percentage of the images scored ≥4 ranged from 61% to 99%, 23% to 92%, and 96% to 99% for the chest, abdomen, and extremity images, respectively. The average score ranged from 3.63 to 4.46, 3.18 to 4.21, and 4.41 to 4.51 for the chest, abdomen, and extremity images, respectively. Conclusion. The phantom image results showed the comparability of these systems. The clinical evaluation showed BodiiRay images provided sufficient image qualities for digital radiography of these body parts.

6 July 2025 in BMJ Open
Verified
Journal Article
Open access
PDF file
LMLihong Mo
Lihong Mo
AAAlfredo Lopez Aguirre
Alfredo Lopez Aguirre
NSNithya Sivakumar
Nithya Sivakumar
SPSakunrat Prompalit
Sakunrat Prompalit
HHHerman Locsin Hedriana
Herman Locsin Hedriana
JHJeffrey S. Hoch
Jeffrey S. Hoch
Introduction Perinatal complications involving conflicts between maternal and fetal health interests present a unique challenge to health economic evaluations. No comprehensive synthesis exists of how such studies account for dual-patient outcomes. We aim to develop a scoping review protocol to map and critically examine the methodologies in this understudied area. Methods and analysis The scoping review will be conducted under the Joanna Briggs Institute (JBI) framework. It will include health economic studies, such as cost-effectiveness, cost utility and decision analysis studies, focusing on clinical conditions during pregnancy where maternal and fetal interests conflict. Cost analysis without effectiveness assessment will be excluded. Using comprehensive search strategies in Medline (Ovid), EMBASE (Elsevier) and Cochrane Library (Wiley), two independent reviewers will screen and identify relevant studies via abstract and full-text review. We will perform data extraction following an adapted form from the Consolidated Health Economic Evaluation Reporting Standards checklist, which includes the content details, such as the type of study, population, intervention, comparator, probability, utility, duration, cost, model types and uncertainty measurements. As we try to explore the impact of the health economic studies in clinical practice, we will include citation metrics of each study and whether the study was cited by practice guidelines and clinical trials in the data extraction. We will also apply the JBI Checklist for Economic Evaluations to assess the reporting completeness in each article. Results will be tabulated by clinical theme and synthesised narratively to highlight patterns in valuation approaches, gaps in current methods and impact on clinical guidelines. Ethics and dissemination This study does not require ethical approval as it involves secondary analysis of published data. Findings will be disseminated through peer-reviewed publications, conference presentations and stakeholder engagement activities. PROSPERO registration number CRD42024557324